Related Experiment Video
Updated: Mar 27, 2026
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
1.0K
Hot topics on diabetes in China
Jianping Weng1,2, Paolo Pozzilli3,4
1Chinese Diabetes Society, Beijing, China.
Diabetes/Metabolism Research and Reviews
|January 16, 2016
Summary
China faces a significant diabetes burden, prompting the Chinese Diabetes Society to coordinate national initiatives. These efforts include guideline implementation, education, prevention trials, and exploring traditional Chinese medicine for diabetes treatment.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Integrative Medicine
Background:
- China has the world's largest diabetes population, necessitating coordinated national strategies.
- The Chinese Diabetes Society plays a central role in managing diabetes nationwide.
- Current initiatives address therapy guidelines, public education, and prevention research.
Purpose of the Study:
- To provide an overview of diabetes management initiatives in China.
- To highlight the role of the Chinese Diabetes Society in coordinating these efforts.
- To introduce the exploration of traditional Chinese medicine as a diabetes therapeutic option.
Main Methods:
- Review of ongoing national diabetes initiatives.
- Description of guideline implementation and educational campaigns.
- Mention of clinical trials for type 2 diabetes prevention.
- Exploration of traditional Chinese medicine research.
Main Results:
- The Chinese Diabetes Society is actively implementing multi-level interventions.
- International collaborations in diabetes research are being established.
- A scientifically grounded approach to investigating traditional Chinese medicine for diabetes is underway.
Conclusions:
- China is actively addressing its substantial diabetes burden through coordinated national actions.
- The Chinese Diabetes Society is instrumental in driving these diverse diabetes management strategies.
- Investigating traditional Chinese medicine offers a novel therapeutic avenue for diabetes care in China.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
922
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
922
01:22Diabetes Mellitus: Type 2 and Gestational
5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K